nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—Fenethylline—Dyphylline—asthma	0.434	1	CrCrCtD
Methamphetamine—SLC22A5—Ipratropium bromide—asthma	0.0842	0.29	CbGbCtD
Methamphetamine—SLC22A5—Tiotropium—asthma	0.0638	0.219	CbGbCtD
Methamphetamine—CYP2D6—Ciclesonide—asthma	0.0243	0.0836	CbGbCtD
Methamphetamine—CYP2D6—Ipratropium bromide—asthma	0.0201	0.0692	CbGbCtD
Methamphetamine—CYP2D6—Zafirlukast—asthma	0.0177	0.061	CbGbCtD
Methamphetamine—CYP2D6—Formoterol—asthma	0.0171	0.0589	CbGbCtD
Methamphetamine—CYP2D6—Arformoterol—asthma	0.0171	0.0589	CbGbCtD
Methamphetamine—CYP2D6—Tiotropium—asthma	0.0153	0.0525	CbGbCtD
Methamphetamine—CYP2D6—Theophylline—asthma	0.0137	0.0471	CbGbCtD
Methamphetamine—CYP2D6—Loratadine—asthma	0.013	0.0446	CbGbCtD
Methamphetamine—CYP2D6—Dexamethasone—asthma	0.00449	0.0154	CbGbCtD
Methamphetamine—TAAR1—respiratory system—asthma	0.00397	0.112	CbGeAlD
Methamphetamine—SLC6A2—autonomic nervous system—asthma	0.0032	0.0904	CbGeAlD
Methamphetamine—SLC18A1—adrenal gland—asthma	0.00256	0.0723	CbGeAlD
Methamphetamine—TAAR1—lung—asthma	0.00211	0.0596	CbGeAlD
Methamphetamine—SLC6A3—respiratory system—asthma	0.00102	0.0288	CbGeAlD
Methamphetamine—SLC6A4—respiratory system—asthma	0.000934	0.0264	CbGeAlD
Methamphetamine—MAOB—respiratory system—asthma	0.000888	0.0251	CbGeAlD
Methamphetamine—SLC6A2—respiratory system—asthma	0.000823	0.0233	CbGeAlD
Methamphetamine—SLC18A2—adrenal gland—asthma	0.000817	0.0231	CbGeAlD
Methamphetamine—SLC22A3—smooth muscle tissue—asthma	0.000773	0.0219	CbGeAlD
Methamphetamine—MAOA—respiratory system—asthma	0.000758	0.0214	CbGeAlD
Methamphetamine—MAOB—adrenal cortex—asthma	0.000745	0.0211	CbGeAlD
Methamphetamine—MAOB—bronchus—asthma	0.000731	0.0207	CbGeAlD
Methamphetamine—SLC18A2—lung—asthma	0.000716	0.0202	CbGeAlD
Methamphetamine—SLC22A5—respiratory system—asthma	0.000698	0.0197	CbGeAlD
Methamphetamine—Pseudoephedrine—IL2—asthma	0.000694	0.292	CrCbGaD
Methamphetamine—MAOB—cardiovascular system—asthma	0.00068	0.0192	CbGeAlD
Methamphetamine—Benzyl alcohol—ALDH2—asthma	0.000639	0.268	CrCbGaD
Methamphetamine—MAOA—adrenal cortex—asthma	0.000636	0.018	CbGeAlD
Methamphetamine—MAOA—bronchus—asthma	0.000624	0.0176	CbGeAlD
Methamphetamine—ADRA2C—adrenal cortex—asthma	0.000612	0.0173	CbGeAlD
Methamphetamine—ADRA2C—bronchus—asthma	0.0006	0.017	CbGeAlD
Methamphetamine—SLC22A5—adrenal cortex—asthma	0.000586	0.0166	CbGeAlD
Methamphetamine—SLC22A3—adrenal gland—asthma	0.000581	0.0164	CbGeAlD
Methamphetamine—MAOA—cardiovascular system—asthma	0.00058	0.0164	CbGeAlD
Methamphetamine—SLC22A5—bronchus—asthma	0.000574	0.0162	CbGeAlD
Methamphetamine—MAOA—trachea—asthma	0.00056	0.0158	CbGeAlD
Methamphetamine—SLC6A3—lung—asthma	0.000541	0.0153	CbGeAlD
Methamphetamine—ADRA2C—trachea—asthma	0.000538	0.0152	CbGeAlD
Methamphetamine—MAOB—adrenal gland—asthma	0.000538	0.0152	CbGeAlD
Methamphetamine—SLC22A5—trachea—asthma	0.000516	0.0146	CbGeAlD
Methamphetamine—SLC22A3—lung—asthma	0.00051	0.0144	CbGeAlD
Methamphetamine—SLC6A2—adrenal gland—asthma	0.000498	0.0141	CbGeAlD
Methamphetamine—SLC6A4—lung—asthma	0.000496	0.014	CbGeAlD
Methamphetamine—Diarrhoea—Zileuton—asthma	0.000481	0.00369	CcSEcCtD
Methamphetamine—Tremor—Aminophylline—asthma	0.000481	0.00369	CcSEcCtD
Methamphetamine—Dizziness—Ketotifen—asthma	0.00048	0.00368	CcSEcCtD
Methamphetamine—Urticaria—Zafirlukast—asthma	0.00048	0.00368	CcSEcCtD
Methamphetamine—ADRA2A—bronchus—asthma	0.000478	0.0135	CbGeAlD
Methamphetamine—Palpitations—Fluticasone Propionate—asthma	0.000478	0.00367	CcSEcCtD
Methamphetamine—Palpitations—Salmeterol—asthma	0.000477	0.00366	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Ciclesonide—asthma	0.000475	0.00365	CcSEcCtD
Methamphetamine—Hypersensitivity—Fluticasone furoate—asthma	0.000474	0.00364	CcSEcCtD
Methamphetamine—MAOB—lung—asthma	0.000472	0.0133	CbGeAlD
Methamphetamine—Agitation—Aminophylline—asthma	0.000471	0.00362	CcSEcCtD
Methamphetamine—Diarrhoea—Orciprenaline—asthma	0.00047	0.00361	CcSEcCtD
Methamphetamine—Dizziness—Zileuton—asthma	0.000465	0.00357	CcSEcCtD
Methamphetamine—Diarrhoea—Nedocromil—asthma	0.00046	0.00353	CcSEcCtD
Methamphetamine—MAOA—adrenal gland—asthma	0.000459	0.013	CbGeAlD
Methamphetamine—Dizziness—Indacaterol—asthma	0.000458	0.00352	CcSEcCtD
Methamphetamine—Diarrhoea—Pirbuterol—asthma	0.000457	0.00351	CcSEcCtD
Methamphetamine—Urticaria—Theophylline—asthma	0.000457	0.00351	CcSEcCtD
Methamphetamine—Urticaria—Beclomethasone—asthma	0.000457	0.00351	CcSEcCtD
Methamphetamine—Headache—Ketotifen—asthma	0.000455	0.00349	CcSEcCtD
Methamphetamine—Dizziness—Orciprenaline—asthma	0.000455	0.00349	CcSEcCtD
Methamphetamine—Palpitations—Aminophylline—asthma	0.000453	0.00348	CcSEcCtD
Methamphetamine—Insomnia—Cromoglicic acid—asthma	0.000452	0.00347	CcSEcCtD
Methamphetamine—Tachycardia—Ipratropium bromide—asthma	0.000446	0.00342	CcSEcCtD
Methamphetamine—Agitation—Loratadine—asthma	0.000445	0.00342	CcSEcCtD
Methamphetamine—Dizziness—Nedocromil—asthma	0.000445	0.00342	CcSEcCtD
Methamphetamine—Hypersensitivity—Zafirlukast—asthma	0.000445	0.00342	CcSEcCtD
Methamphetamine—Dizziness—Pirbuterol—asthma	0.000442	0.00339	CcSEcCtD
Methamphetamine—ADRA2C—adrenal gland—asthma	0.000441	0.0125	CbGeAlD
Methamphetamine—Headache—Zileuton—asthma	0.00044	0.00338	CcSEcCtD
Methamphetamine—Dyspepsia—Cromoglicic acid—asthma	0.00044	0.00338	CcSEcCtD
Methamphetamine—Diarrhoea—Fluticasone furoate—asthma	0.00044	0.00338	CcSEcCtD
Methamphetamine—Urticaria—Ciclesonide—asthma	0.000437	0.00335	CcSEcCtD
Methamphetamine—SLC6A2—lung—asthma	0.000437	0.0124	CbGeAlD
Methamphetamine—Headache—Indacaterol—asthma	0.000434	0.00333	CcSEcCtD
Methamphetamine—Tachycardia—Fluticasone Propionate—asthma	0.000431	0.00331	CcSEcCtD
Methamphetamine—Headache—Orciprenaline—asthma	0.000431	0.00331	CcSEcCtD
Methamphetamine—Tachycardia—Salmeterol—asthma	0.00043	0.0033	CcSEcCtD
Methamphetamine—ADRA2A—trachea—asthma	0.00043	0.0122	CbGeAlD
Methamphetamine—Palpitations—Loratadine—asthma	0.000428	0.00329	CcSEcCtD
Methamphetamine—Palpitations—Tiotropium—asthma	0.000427	0.00328	CcSEcCtD
Methamphetamine—Constipation—Cromoglicic acid—asthma	0.000427	0.00328	CcSEcCtD
Methamphetamine—Dizziness—Fluticasone furoate—asthma	0.000425	0.00326	CcSEcCtD
Methamphetamine—Hypersensitivity—Theophylline—asthma	0.000424	0.00325	CcSEcCtD
Methamphetamine—SLC22A5—adrenal gland—asthma	0.000423	0.012	CbGeAlD
Methamphetamine—Headache—Nedocromil—asthma	0.000422	0.00324	CcSEcCtD
Methamphetamine—Tremor—Flunisolide—asthma	0.00042	0.00322	CcSEcCtD
Methamphetamine—Headache—Pirbuterol—asthma	0.000419	0.00321	CcSEcCtD
Methamphetamine—Euphoric mood—Prednisolone—asthma	0.000416	0.00319	CcSEcCtD
Methamphetamine—Diarrhoea—Zafirlukast—asthma	0.000413	0.00317	CcSEcCtD
Methamphetamine—Insomnia—Ipratropium bromide—asthma	0.000413	0.00317	CcSEcCtD
Methamphetamine—Agitation—Flunisolide—asthma	0.000412	0.00316	CcSEcCtD
Methamphetamine—Tachycardia—Aminophylline—asthma	0.000409	0.00314	CcSEcCtD
Methamphetamine—Euphoric mood—Hydrocortisone—asthma	0.000406	0.00312	CcSEcCtD
Methamphetamine—Headache—Fluticasone furoate—asthma	0.000403	0.00309	CcSEcCtD
Methamphetamine—MAOA—lung—asthma	0.000402	0.0114	CbGeAlD
Methamphetamine—Dyspepsia—Ipratropium bromide—asthma	0.000402	0.00308	CcSEcCtD
Methamphetamine—Dizziness—Zafirlukast—asthma	0.000399	0.00307	CcSEcCtD
Methamphetamine—Insomnia—Salmeterol—asthma	0.000399	0.00306	CcSEcCtD
Methamphetamine—Urticaria—Cromoglicic acid—asthma	0.000397	0.00305	CcSEcCtD
Methamphetamine—Palpitations—Flunisolide—asthma	0.000396	0.00304	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Ipratropium bromide—asthma	0.000394	0.00303	CcSEcCtD
Methamphetamine—Diarrhoea—Theophylline—asthma	0.000393	0.00302	CcSEcCtD
Methamphetamine—Constipation—Ipratropium bromide—asthma	0.00039	0.003	CcSEcCtD
Methamphetamine—Dyspepsia—Salmeterol—asthma	0.000388	0.00298	CcSEcCtD
Methamphetamine—ADRA2C—lung—asthma	0.000387	0.0109	CbGeAlD
Methamphetamine—Tachycardia—Loratadine—asthma	0.000386	0.00296	CcSEcCtD
Methamphetamine—Tachycardia—Tiotropium—asthma	0.000385	0.00296	CcSEcCtD
Methamphetamine—Euphoric mood—Triamcinolone—asthma	0.000382	0.00293	CcSEcCtD
Methamphetamine—Euphoric mood—Methylprednisolone—asthma	0.000381	0.00293	CcSEcCtD
Methamphetamine—Dizziness—Theophylline—asthma	0.00038	0.00292	CcSEcCtD
Methamphetamine—Dizziness—Beclomethasone—asthma	0.00038	0.00292	CcSEcCtD
Methamphetamine—Insomnia—Aminophylline—asthma	0.000379	0.00291	CcSEcCtD
Methamphetamine—Headache—Zafirlukast—asthma	0.000378	0.0029	CcSEcCtD
Methamphetamine—Constipation—Salmeterol—asthma	0.000377	0.00289	CcSEcCtD
Methamphetamine—SLC22A5—lung—asthma	0.000371	0.0105	CbGeAlD
Methamphetamine—Dyspepsia—Aminophylline—asthma	0.000369	0.00283	CcSEcCtD
Methamphetamine—Hypersensitivity—Cromoglicic acid—asthma	0.000368	0.00283	CcSEcCtD
Methamphetamine—Tremor—Arformoterol—asthma	0.000366	0.00281	CcSEcCtD
Methamphetamine—Tremor—Formoterol—asthma	0.000366	0.00281	CcSEcCtD
Methamphetamine—Dizziness—Ciclesonide—asthma	0.000364	0.00279	CcSEcCtD
Methamphetamine—Urticaria—Ipratropium bromide—asthma	0.000363	0.00278	CcSEcCtD
Methamphetamine—Headache—Beclomethasone—asthma	0.00036	0.00276	CcSEcCtD
Methamphetamine—Headache—Theophylline—asthma	0.00036	0.00276	CcSEcCtD
Methamphetamine—Agitation—Formoterol—asthma	0.000359	0.00275	CcSEcCtD
Methamphetamine—Agitation—Arformoterol—asthma	0.000359	0.00275	CcSEcCtD
Methamphetamine—Tremor—Montelukast—asthma	0.000358	0.00275	CcSEcCtD
Methamphetamine—Insomnia—Loratadine—asthma	0.000358	0.00275	CcSEcCtD
Methamphetamine—Tachycardia—Flunisolide—asthma	0.000357	0.00274	CcSEcCtD
Methamphetamine—Insomnia—Tiotropium—asthma	0.000357	0.00274	CcSEcCtD
Methamphetamine—ADRA2A—adrenal gland—asthma	0.000352	0.00996	CbGeAlD
Methamphetamine—Agitation—Montelukast—asthma	0.000351	0.0027	CcSEcCtD
Methamphetamine—Urticaria—Fluticasone Propionate—asthma	0.000351	0.00269	CcSEcCtD
Methamphetamine—Urticaria—Salmeterol—asthma	0.00035	0.00269	CcSEcCtD
Methamphetamine—Dyspepsia—Loratadine—asthma	0.000348	0.00267	CcSEcCtD
Methamphetamine—Dyspepsia—Tiotropium—asthma	0.000348	0.00267	CcSEcCtD
Methamphetamine—Euphoric mood—Betamethasone—asthma	0.000347	0.00266	CcSEcCtD
Methamphetamine—Euphoric mood—Dexamethasone—asthma	0.000347	0.00266	CcSEcCtD
Methamphetamine—Tremor—Salbutamol—asthma	0.000345	0.00265	CcSEcCtD
Methamphetamine—Palpitations—Arformoterol—asthma	0.000345	0.00265	CcSEcCtD
Methamphetamine—Palpitations—Formoterol—asthma	0.000345	0.00265	CcSEcCtD
Methamphetamine—Headache—Ciclesonide—asthma	0.000345	0.00265	CcSEcCtD
Methamphetamine—Diarrhoea—Cromoglicic acid—asthma	0.000342	0.00263	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Loratadine—asthma	0.000341	0.00262	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Tiotropium—asthma	0.000341	0.00262	CcSEcCtD
Methamphetamine—Agitation—Salbutamol—asthma	0.000339	0.0026	CcSEcCtD
Methamphetamine—Constipation—Loratadine—asthma	0.000338	0.0026	CcSEcCtD
Methamphetamine—Palpitations—Montelukast—asthma	0.000338	0.00259	CcSEcCtD
Methamphetamine—Constipation—Tiotropium—asthma	0.000338	0.00259	CcSEcCtD
Methamphetamine—Hypersensitivity—Ipratropium bromide—asthma	0.000336	0.00258	CcSEcCtD
Methamphetamine—Psychotic disorder—Hydrocortisone—asthma	0.000335	0.00257	CcSEcCtD
Methamphetamine—Tremor—Budesonide—asthma	0.000335	0.00257	CcSEcCtD
Methamphetamine—Urticaria—Aminophylline—asthma	0.000333	0.00255	CcSEcCtD
Methamphetamine—Insomnia—Flunisolide—asthma	0.000331	0.00254	CcSEcCtD
Methamphetamine—Dizziness—Cromoglicic acid—asthma	0.000331	0.00254	CcSEcCtD
Methamphetamine—Agitation—Budesonide—asthma	0.000328	0.00252	CcSEcCtD
Methamphetamine—Palpitations—Salbutamol—asthma	0.000326	0.0025	CcSEcCtD
Methamphetamine—Hypersensitivity—Fluticasone Propionate—asthma	0.000326	0.0025	CcSEcCtD
Methamphetamine—Hypersensitivity—Salmeterol—asthma	0.000325	0.00249	CcSEcCtD
Methamphetamine—Dyspepsia—Flunisolide—asthma	0.000322	0.00247	CcSEcCtD
Methamphetamine—Palpitations—Budesonide—asthma	0.000316	0.00242	CcSEcCtD
Methamphetamine—Psychotic disorder—Methylprednisolone—asthma	0.000315	0.00242	CcSEcCtD
Methamphetamine—Urticaria—Tiotropium—asthma	0.000314	0.00241	CcSEcCtD
Methamphetamine—Headache—Cromoglicic acid—asthma	0.000313	0.0024	CcSEcCtD
Methamphetamine—Constipation—Flunisolide—asthma	0.000313	0.0024	CcSEcCtD
Methamphetamine—Diarrhoea—Ipratropium bromide—asthma	0.000312	0.0024	CcSEcCtD
Methamphetamine—Tachycardia—Arformoterol—asthma	0.000311	0.00239	CcSEcCtD
Methamphetamine—Tachycardia—Formoterol—asthma	0.000311	0.00239	CcSEcCtD
Methamphetamine—ADRA2A—lung—asthma	0.000309	0.00873	CbGeAlD
Methamphetamine—Hypersensitivity—Aminophylline—asthma	0.000308	0.00237	CcSEcCtD
Methamphetamine—Diarrhoea—Fluticasone Propionate—asthma	0.000302	0.00232	CcSEcCtD
Methamphetamine—Euphoric mood—Prednisone—asthma	0.000302	0.00232	CcSEcCtD
Methamphetamine—Dizziness—Ipratropium bromide—asthma	0.000302	0.00232	CcSEcCtD
Methamphetamine—Diarrhoea—Salmeterol—asthma	0.000302	0.00232	CcSEcCtD
Methamphetamine—Dyspepsia—Mometasone—asthma	0.000299	0.00229	CcSEcCtD
Methamphetamine—Tachycardia—Salbutamol—asthma	0.000294	0.00225	CcSEcCtD
Methamphetamine—Dizziness—Fluticasone Propionate—asthma	0.000292	0.00224	CcSEcCtD
Methamphetamine—Dizziness—Salmeterol—asthma	0.000292	0.00224	CcSEcCtD
Methamphetamine—Hypersensitivity—Tiotropium—asthma	0.000291	0.00223	CcSEcCtD
Methamphetamine—Urticaria—Flunisolide—asthma	0.000291	0.00223	CcSEcCtD
Methamphetamine—Insomnia—Formoterol—asthma	0.000288	0.00221	CcSEcCtD
Methamphetamine—Insomnia—Arformoterol—asthma	0.000288	0.00221	CcSEcCtD
Methamphetamine—Diarrhoea—Aminophylline—asthma	0.000286	0.0022	CcSEcCtD
Methamphetamine—Psychotic disorder—Dexamethasone—asthma	0.000286	0.0022	CcSEcCtD
Methamphetamine—Psychotic disorder—Betamethasone—asthma	0.000286	0.0022	CcSEcCtD
Methamphetamine—Headache—Ipratropium bromide—asthma	0.000286	0.0022	CcSEcCtD
Methamphetamine—Tachycardia—Budesonide—asthma	0.000284	0.00218	CcSEcCtD
Methamphetamine—Insomnia—Montelukast—asthma	0.000282	0.00217	CcSEcCtD
Methamphetamine—Dyspepsia—Arformoterol—asthma	0.00028	0.00215	CcSEcCtD
Methamphetamine—Dyspepsia—Formoterol—asthma	0.00028	0.00215	CcSEcCtD
Methamphetamine—Dizziness—Aminophylline—asthma	0.000277	0.00213	CcSEcCtD
Methamphetamine—Headache—Fluticasone Propionate—asthma	0.000277	0.00213	CcSEcCtD
Methamphetamine—Headache—Salmeterol—asthma	0.000276	0.00212	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Formoterol—asthma	0.000275	0.00211	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Arformoterol—asthma	0.000275	0.00211	CcSEcCtD
Methamphetamine—Dyspepsia—Montelukast—asthma	0.000275	0.00211	CcSEcCtD
Methamphetamine—Ephedrine—ADRB2—asthma	0.000274	0.115	CrCbGaD
Methamphetamine—Constipation—Formoterol—asthma	0.000272	0.00209	CcSEcCtD
Methamphetamine—Constipation—Arformoterol—asthma	0.000272	0.00209	CcSEcCtD
Methamphetamine—Insomnia—Salbutamol—asthma	0.000272	0.00209	CcSEcCtD
Methamphetamine—Diarrhoea—Loratadine—asthma	0.000271	0.00208	CcSEcCtD
Methamphetamine—Hypersensitivity—Flunisolide—asthma	0.00027	0.00207	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Montelukast—asthma	0.000269	0.00207	CcSEcCtD
Methamphetamine—Dyspepsia—Salbutamol—asthma	0.000265	0.00203	CcSEcCtD
Methamphetamine—Insomnia—Budesonide—asthma	0.000264	0.00202	CcSEcCtD
Methamphetamine—Headache—Aminophylline—asthma	0.000262	0.00201	CcSEcCtD
Methamphetamine—Dizziness—Loratadine—asthma	0.000262	0.00201	CcSEcCtD
Methamphetamine—Dizziness—Tiotropium—asthma	0.000261	0.002	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Salbutamol—asthma	0.00026	0.00199	CcSEcCtD
Methamphetamine—Constipation—Salbutamol—asthma	0.000257	0.00197	CcSEcCtD
Methamphetamine—Dyspepsia—Budesonide—asthma	0.000257	0.00197	CcSEcCtD
Methamphetamine—Urticaria—Arformoterol—asthma	0.000253	0.00194	CcSEcCtD
Methamphetamine—Urticaria—Formoterol—asthma	0.000253	0.00194	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Budesonide—asthma	0.000252	0.00193	CcSEcCtD
Methamphetamine—Diarrhoea—Flunisolide—asthma	0.00025	0.00192	CcSEcCtD
Methamphetamine—Constipation—Budesonide—asthma	0.000249	0.00191	CcSEcCtD
Methamphetamine—Psychotic disorder—Prednisone—asthma	0.000249	0.00191	CcSEcCtD
Methamphetamine—Urticaria—Montelukast—asthma	0.000248	0.0019	CcSEcCtD
Methamphetamine—Headache—Loratadine—asthma	0.000248	0.0019	CcSEcCtD
Methamphetamine—Headache—Tiotropium—asthma	0.000247	0.0019	CcSEcCtD
Methamphetamine—Phenylpropanolamine—ADRB2—asthma	0.000246	0.103	CrCbGaD
Methamphetamine—Dizziness—Flunisolide—asthma	0.000242	0.00186	CcSEcCtD
Methamphetamine—Urticaria—Salbutamol—asthma	0.000239	0.00183	CcSEcCtD
Methamphetamine—Hypersensitivity—Arformoterol—asthma	0.000235	0.0018	CcSEcCtD
Methamphetamine—Hypersensitivity—Formoterol—asthma	0.000235	0.0018	CcSEcCtD
Methamphetamine—Pseudoephedrine—TNF—asthma	0.000234	0.0984	CrCbGaD
Methamphetamine—Diarrhoea—Mometasone—asthma	0.000232	0.00178	CcSEcCtD
Methamphetamine—Urticaria—Budesonide—asthma	0.000232	0.00178	CcSEcCtD
Methamphetamine—Hypersensitivity—Montelukast—asthma	0.00023	0.00177	CcSEcCtD
Methamphetamine—Headache—Flunisolide—asthma	0.000229	0.00176	CcSEcCtD
Methamphetamine—Hypersensitivity—Salbutamol—asthma	0.000222	0.0017	CcSEcCtD
Methamphetamine—Diarrhoea—Formoterol—asthma	0.000218	0.00167	CcSEcCtD
Methamphetamine—Diarrhoea—Arformoterol—asthma	0.000218	0.00167	CcSEcCtD
Methamphetamine—Hypersensitivity—Budesonide—asthma	0.000215	0.00165	CcSEcCtD
Methamphetamine—Diarrhoea—Montelukast—asthma	0.000214	0.00164	CcSEcCtD
Methamphetamine—Headache—Mometasone—asthma	0.000213	0.00163	CcSEcCtD
Methamphetamine—Dizziness—Arformoterol—asthma	0.000211	0.00162	CcSEcCtD
Methamphetamine—Dizziness—Formoterol—asthma	0.000211	0.00162	CcSEcCtD
Methamphetamine—Pseudoephedrine—ADRB2—asthma	0.000208	0.0872	CrCbGaD
Methamphetamine—Dizziness—Montelukast—asthma	0.000206	0.00158	CcSEcCtD
Methamphetamine—Diarrhoea—Salbutamol—asthma	0.000206	0.00158	CcSEcCtD
Methamphetamine—Erectile dysfunction—Prednisone—asthma	0.000203	0.00156	CcSEcCtD
Methamphetamine—Headache—Arformoterol—asthma	0.0002	0.00153	CcSEcCtD
Methamphetamine—Headache—Formoterol—asthma	0.0002	0.00153	CcSEcCtD
Methamphetamine—Diarrhoea—Budesonide—asthma	0.000199	0.00153	CcSEcCtD
Methamphetamine—Dizziness—Salbutamol—asthma	0.000199	0.00153	CcSEcCtD
Methamphetamine—Headache—Montelukast—asthma	0.000196	0.0015	CcSEcCtD
Methamphetamine—Dizziness—Budesonide—asthma	0.000193	0.00148	CcSEcCtD
Methamphetamine—Headache—Salbutamol—asthma	0.000188	0.00145	CcSEcCtD
Methamphetamine—Headache—Budesonide—asthma	0.000183	0.0014	CcSEcCtD
Methamphetamine—Tachycardia—Prednisolone—asthma	0.000168	0.00129	CcSEcCtD
Methamphetamine—Tachycardia—Hydrocortisone—asthma	0.000164	0.00126	CcSEcCtD
Methamphetamine—Insomnia—Prednisolone—asthma	0.000156	0.0012	CcSEcCtD
Methamphetamine—Tachycardia—Triamcinolone—asthma	0.000155	0.00119	CcSEcCtD
Methamphetamine—Tachycardia—Methylprednisolone—asthma	0.000155	0.00119	CcSEcCtD
Methamphetamine—Insomnia—Hydrocortisone—asthma	0.000152	0.00117	CcSEcCtD
Methamphetamine—Dyspepsia—Hydrocortisone—asthma	0.000148	0.00114	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Hydrocortisone—asthma	0.000145	0.00112	CcSEcCtD
Methamphetamine—Insomnia—Triamcinolone—asthma	0.000144	0.0011	CcSEcCtD
Methamphetamine—Insomnia—Methylprednisolone—asthma	0.000143	0.0011	CcSEcCtD
Methamphetamine—Agitation—Prednisone—asthma	0.000141	0.00108	CcSEcCtD
Methamphetamine—Tachycardia—Betamethasone—asthma	0.000141	0.00108	CcSEcCtD
Methamphetamine—Tachycardia—Dexamethasone—asthma	0.000141	0.00108	CcSEcCtD
Methamphetamine—Dyspepsia—Triamcinolone—asthma	0.00014	0.00107	CcSEcCtD
Methamphetamine—Dyspepsia—Methylprednisolone—asthma	0.000139	0.00107	CcSEcCtD
Methamphetamine—Urticaria—Prednisolone—asthma	0.000137	0.00105	CcSEcCtD
Methamphetamine—Urticaria—Hydrocortisone—asthma	0.000134	0.00103	CcSEcCtD
Methamphetamine—Insomnia—Betamethasone—asthma	0.00013	0.001	CcSEcCtD
Methamphetamine—Insomnia—Dexamethasone—asthma	0.00013	0.001	CcSEcCtD
Methamphetamine—Hypersensitivity—Prednisolone—asthma	0.000127	0.000976	CcSEcCtD
Methamphetamine—Dyspepsia—Dexamethasone—asthma	0.000127	0.000973	CcSEcCtD
Methamphetamine—Dyspepsia—Betamethasone—asthma	0.000127	0.000973	CcSEcCtD
Methamphetamine—Urticaria—Triamcinolone—asthma	0.000126	0.000968	CcSEcCtD
Methamphetamine—Urticaria—Methylprednisolone—asthma	0.000126	0.000966	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Dexamethasone—asthma	0.000124	0.000954	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Betamethasone—asthma	0.000124	0.000954	CcSEcCtD
Methamphetamine—Hypersensitivity—Hydrocortisone—asthma	0.000124	0.000953	CcSEcCtD
Methamphetamine—Tachycardia—Prednisone—asthma	0.000122	0.000939	CcSEcCtD
Methamphetamine—Hypersensitivity—Triamcinolone—asthma	0.000117	0.000897	CcSEcCtD
Methamphetamine—Hypersensitivity—Methylprednisolone—asthma	0.000117	0.000895	CcSEcCtD
Methamphetamine—Diarrhoea—Hydrocortisone—asthma	0.000115	0.000885	CcSEcCtD
Methamphetamine—Urticaria—Dexamethasone—asthma	0.000114	0.000878	CcSEcCtD
Methamphetamine—Urticaria—Betamethasone—asthma	0.000114	0.000878	CcSEcCtD
Methamphetamine—Dizziness—Prednisolone—asthma	0.000114	0.000876	CcSEcCtD
Methamphetamine—Insomnia—Prednisone—asthma	0.000113	0.000871	CcSEcCtD
Methamphetamine—Dizziness—Hydrocortisone—asthma	0.000111	0.000856	CcSEcCtD
Methamphetamine—Dyspepsia—Prednisone—asthma	0.00011	0.000847	CcSEcCtD
Methamphetamine—Diarrhoea—Methylprednisolone—asthma	0.000108	0.000832	CcSEcCtD
Methamphetamine—Headache—Prednisolone—asthma	0.000108	0.00083	CcSEcCtD
Methamphetamine—Constipation—Prednisone—asthma	0.000107	0.000823	CcSEcCtD
Methamphetamine—Headache—Hydrocortisone—asthma	0.000106	0.00081	CcSEcCtD
Methamphetamine—Dizziness—Triamcinolone—asthma	0.000105	0.000806	CcSEcCtD
Methamphetamine—Dizziness—Methylprednisolone—asthma	0.000105	0.000804	CcSEcCtD
Methamphetamine—Urticaria—Prednisone—asthma	9.96e-05	0.000765	CcSEcCtD
Methamphetamine—Headache—Triamcinolone—asthma	9.94e-05	0.000763	CcSEcCtD
Methamphetamine—Headache—Methylprednisolone—asthma	9.92e-05	0.000761	CcSEcCtD
Methamphetamine—Diarrhoea—Betamethasone—asthma	9.85e-05	0.000756	CcSEcCtD
Methamphetamine—Diarrhoea—Dexamethasone—asthma	9.85e-05	0.000756	CcSEcCtD
Methamphetamine—Dizziness—Betamethasone—asthma	9.52e-05	0.000731	CcSEcCtD
Methamphetamine—Dizziness—Dexamethasone—asthma	9.52e-05	0.000731	CcSEcCtD
Methamphetamine—Hypersensitivity—Prednisone—asthma	9.24e-05	0.000709	CcSEcCtD
Methamphetamine—Headache—Dexamethasone—asthma	9.02e-05	0.000692	CcSEcCtD
Methamphetamine—Headache—Betamethasone—asthma	9.02e-05	0.000692	CcSEcCtD
Methamphetamine—Nateglinide—ALB—asthma	8.66e-05	0.0363	CrCbGaD
Methamphetamine—Diarrhoea—Prednisone—asthma	8.58e-05	0.000659	CcSEcCtD
Methamphetamine—Dizziness—Prednisone—asthma	8.29e-05	0.000637	CcSEcCtD
Methamphetamine—Headache—Prednisone—asthma	7.86e-05	0.000603	CcSEcCtD
Methamphetamine—ADRA2A—Signaling Pathways—PDE4B—asthma	9.2e-06	8.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—C5—asthma	9.2e-06	8.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TACR1—asthma	9.2e-06	8.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CXCL8—asthma	9.2e-06	8.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL5—asthma	9.19e-06	8.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PARP1—asthma	9.19e-06	8.57e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PLA2G4A—asthma	9.13e-06	8.51e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GSTM1—asthma	9.13e-06	8.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCR3—asthma	9.06e-06	8.44e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—NOS3—asthma	8.97e-06	8.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—BDKRB2—asthma	8.87e-06	8.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—POMC—asthma	8.85e-06	8.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—VEGFA—asthma	8.8e-06	8.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CYBA—asthma	8.77e-06	8.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—EDN1—asthma	8.73e-06	8.14e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—POMC—asthma	8.7e-06	8.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL5—asthma	8.66e-06	8.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PLA2G4A—asthma	8.63e-06	8.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCR5—asthma	8.6e-06	8.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL5—asthma	8.58e-06	8e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PARP1—asthma	8.58e-06	8e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADCY2—asthma	8.58e-06	8e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL3—asthma	8.55e-06	7.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CSF2—asthma	8.53e-06	7.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2RA—asthma	8.47e-06	7.9e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALOX15—asthma	8.43e-06	7.86e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALOX5AP—asthma	8.43e-06	7.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR3—asthma	8.42e-06	7.85e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PPP2CA—asthma	8.4e-06	7.84e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—C3—asthma	8.4e-06	7.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—BDKRB2—asthma	8.28e-06	7.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—POMC—asthma	8.27e-06	7.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—VEGFA—asthma	8.22e-06	7.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NPY—asthma	8.2e-06	7.65e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—asthma	8.2e-06	7.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTP1—asthma	8.17e-06	7.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TGFB1—asthma	8.08e-06	7.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KNG1—asthma	8.07e-06	7.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—HMOX1—asthma	8.06e-06	7.51e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CHAT—asthma	8.04e-06	7.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—POMC—asthma	8.04e-06	7.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ITPR1—asthma	8.04e-06	7.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AGTR1—asthma	8.02e-06	7.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADCY2—asthma	8.01e-06	7.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL3—asthma	7.99e-06	7.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NQO1—asthma	7.96e-06	7.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CAT—asthma	7.95e-06	7.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PPP2CA—asthma	7.95e-06	7.41e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ALB—asthma	7.93e-06	7.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AGTR2—asthma	7.91e-06	7.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCL2—asthma	7.87e-06	7.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IL2—asthma	7.86e-06	7.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6R—asthma	7.84e-06	7.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL10—asthma	7.84e-06	7.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCR5—asthma	7.81e-06	7.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—RHOA—asthma	7.8e-06	7.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ADCY2—asthma	7.79e-06	7.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2RA—asthma	7.69e-06	7.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NTRK1—asthma	7.69e-06	7.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—C3—asthma	7.63e-06	7.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADRB2—asthma	7.61e-06	7.09e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—NOS3—asthma	7.59e-06	7.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EDNRB—asthma	7.58e-06	7.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TGFB1—asthma	7.55e-06	7.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KNG1—asthma	7.54e-06	7.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—POMC—asthma	7.51e-06	7e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PLA2G4A—asthma	7.51e-06	7e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTM1—asthma	7.51e-06	7e-05	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6—asthma	7.5e-06	6.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TAC1—asthma	7.5e-06	6.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NPS—asthma	7.5e-06	6.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AGTR1—asthma	7.49e-06	6.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCR3—asthma	7.36e-06	6.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCL2—asthma	7.35e-06	6.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6R—asthma	7.33e-06	6.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL10—asthma	7.32e-06	6.82e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—RHOA—asthma	7.29e-06	6.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ITPR1—asthma	7.2e-06	6.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NTRK1—asthma	7.18e-06	6.7e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALOX5—asthma	7.17e-06	6.68e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTEN—asthma	7.15e-06	6.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CYBA—asthma	7.12e-06	6.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADRB2—asthma	7.11e-06	6.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—RHOA—asthma	7.08e-06	6.61e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PARP1—asthma	6.97e-06	6.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL5—asthma	6.97e-06	6.5e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—asthma	6.94e-06	6.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPP2CA—asthma	6.91e-06	6.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CD86—asthma	6.85e-06	6.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CXCL8—asthma	6.85e-06	6.39e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CARM1—asthma	6.84e-06	6.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EDN1—asthma	6.8e-06	6.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL5—asthma	6.75e-06	6.29e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—DCN—asthma	6.74e-06	6.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BDKRB2—asthma	6.73e-06	6.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ITPR1—asthma	6.72e-06	6.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PLA2G4A—asthma	6.72e-06	6.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—POMC—asthma	6.72e-06	6.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—VEGFA—asthma	6.68e-06	6.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CSF2—asthma	6.64e-06	6.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTP1—asthma	6.64e-06	6.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—RHOA—asthma	6.62e-06	6.17e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALDH2—asthma	6.56e-06	6.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—IL2—asthma	6.55e-06	6.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—HMOX1—asthma	6.54e-06	6.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ITPR1—asthma	6.53e-06	6.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADCY2—asthma	6.51e-06	6.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL3—asthma	6.49e-06	6.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SMAD3—asthma	6.47e-06	6.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CAT—asthma	6.46e-06	6.02e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—POMC—asthma	6.45e-06	6.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CD86—asthma	6.4e-06	5.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CXCL8—asthma	6.4e-06	5.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EDN1—asthma	6.35e-06	5.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL5—asthma	6.3e-06	5.87e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PLA2G4A—asthma	6.28e-06	5.85e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTT1—asthma	6.24e-06	5.82e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CXCL8—asthma	6.22e-06	5.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CSF2—asthma	6.21e-06	5.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PPP2CA—asthma	6.19e-06	5.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TGFB1—asthma	6.13e-06	5.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KNG1—asthma	6.12e-06	5.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2—asthma	6.11e-06	5.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—POMC—asthma	6.1e-06	5.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PLA2G4A—asthma	6.1e-06	5.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTM1—asthma	6.1e-06	5.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AGTR1—asthma	6.08e-06	5.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCR5—asthma	6.08e-06	5.67e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTEN—asthma	6.05e-06	5.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SMAD3—asthma	6.04e-06	5.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2RA—asthma	5.99e-06	5.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL2—asthma	5.97e-06	5.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6R—asthma	5.95e-06	5.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL10—asthma	5.95e-06	5.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2—asthma	5.94e-06	5.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—C3—asthma	5.94e-06	5.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—RHOA—asthma	5.92e-06	5.52e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ALB—asthma	5.88e-06	5.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NTRK1—asthma	5.83e-06	5.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CXCL8—asthma	5.81e-06	5.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PPP2CA—asthma	5.78e-06	5.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PDGFB—asthma	5.78e-06	5.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADRB2—asthma	5.77e-06	5.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCR5—asthma	5.68e-06	5.29e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—NOS3—asthma	5.63e-06	5.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPP2CA—asthma	5.62e-06	5.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2RA—asthma	5.59e-06	5.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2—asthma	5.55e-06	5.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—C3—asthma	5.55e-06	5.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LEP—asthma	5.53e-06	5.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ITPR1—asthma	5.46e-06	5.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PDGFB—asthma	5.4e-06	5.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—RHOA—asthma	5.38e-06	5.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—POMC—asthma	5.31e-06	4.95e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FN1—asthma	5.21e-06	4.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CD86—asthma	5.2e-06	4.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCL8—asthma	5.2e-06	4.84e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NQO1—asthma	5.18e-06	4.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LEP—asthma	5.16e-06	4.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EDN1—asthma	5.16e-06	4.81e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—asthma	5.15e-06	4.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL5—asthma	5.12e-06	4.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PLA2G4A—asthma	5.1e-06	4.75e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADCY2—asthma	5.07e-06	4.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CSF2—asthma	5.04e-06	4.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2—asthma	4.97e-06	4.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SMAD3—asthma	4.91e-06	4.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FN1—asthma	4.87e-06	4.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—asthma	4.84e-06	4.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—POMC—asthma	4.75e-06	4.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL8—asthma	4.72e-06	4.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PPP2CA—asthma	4.7e-06	4.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL2—asthma	4.65e-06	4.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6R—asthma	4.63e-06	4.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NOS3—asthma	4.63e-06	4.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR5—asthma	4.61e-06	4.3e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—EGFR—asthma	4.55e-06	4.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2RA—asthma	4.54e-06	4.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2—asthma	4.51e-06	4.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—C3—asthma	4.51e-06	4.2e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTEN—asthma	4.49e-06	4.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—POMC—asthma	4.44e-06	4.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PDGFB—asthma	4.39e-06	4.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL2—asthma	4.34e-06	4.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SERPINE1—asthma	4.34e-06	4.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6R—asthma	4.33e-06	4.03e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTP1—asthma	4.32e-06	4.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—POMC—asthma	4.31e-06	4.02e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HMOX1—asthma	4.26e-06	3.98e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ITPR1—asthma	4.25e-06	3.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—EGFR—asthma	4.25e-06	3.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—asthma	4.23e-06	3.95e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CAT—asthma	4.21e-06	3.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LEP—asthma	4.19e-06	3.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RHOA—asthma	4.19e-06	3.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOS3—asthma	4.14e-06	3.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SERPINE1—asthma	4.05e-06	3.78e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTM1—asthma	3.97e-06	3.7e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PLA2G4A—asthma	3.97e-06	3.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FN1—asthma	3.96e-06	3.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—asthma	3.93e-06	3.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RHOA—asthma	3.91e-06	3.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOS3—asthma	3.87e-06	3.61e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NOS3—asthma	3.76e-06	3.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTEN—asthma	3.69e-06	3.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL8—asthma	3.67e-06	3.43e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPP2CA—asthma	3.66e-06	3.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—POMC—asthma	3.6e-06	3.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL2—asthma	3.53e-06	3.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6R—asthma	3.52e-06	3.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2—asthma	3.51e-06	3.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—asthma	3.49e-06	3.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—EGFR—asthma	3.45e-06	3.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—asthma	3.44e-06	3.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL8—asthma	3.43e-06	3.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP9—asthma	3.32e-06	3.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTEN—asthma	3.3e-06	3.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SERPINE1—asthma	3.29e-06	3.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2—asthma	3.28e-06	3.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—asthma	3.26e-06	3.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RHOA—asthma	3.18e-06	2.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOS3—asthma	3.14e-06	2.93e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP9—asthma	3.1e-06	2.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTEN—asthma	3.09e-06	2.88e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTEN—asthma	3e-06	2.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—VEGFA—asthma	2.98e-06	2.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—STAT3—asthma	2.95e-06	2.75e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—POMC—asthma	2.81e-06	2.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL8—asthma	2.79e-06	2.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—VEGFA—asthma	2.79e-06	2.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—STAT3—asthma	2.76e-06	2.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFB1—asthma	2.74e-06	2.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EGFR—asthma	2.69e-06	2.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2—asthma	2.66e-06	2.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—asthma	2.65e-06	2.47e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—asthma	2.56e-06	2.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFB1—asthma	2.56e-06	2.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP9—asthma	2.52e-06	2.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EGFR—asthma	2.51e-06	2.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTEN—asthma	2.51e-06	2.34e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NOS3—asthma	2.45e-06	2.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VEGFA—asthma	2.26e-06	2.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—STAT3—asthma	2.24e-06	2.09e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—asthma	2.24e-06	2.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFB1—asthma	2.08e-06	1.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—asthma	2.06e-06	1.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EGFR—asthma	2.04e-06	1.9e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTEN—asthma	1.95e-06	1.82e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—asthma	1.93e-06	1.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—asthma	1.57e-06	1.46e-05	CbGpPWpGaD
